Atara Biotherapeutics, Inc. (ATRA) Social Stream



Atara Biotherapeutics, Inc. (ATRA): $14.86

0.60 (+4.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ATRA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 455

in industry

Atara Biotherapeutics Inc (ATRA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Atara Biotherapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-24 5 $31 $24 $27.5 $15.25 80.33%
2021-11-04 7 $31 $26 $27.8 $15.25 82.3%
2021-12-09 7 $31 $26 $28 $15.25 83.61%
2021-12-13 6 $31 $26 $28 $15.25 83.61%
2021-12-15 5 $31 $24 $27.25 $15.25 78.69%
2021-12-15 6 $31 $24 $27.25 $15.25 78.69%

The Trend in the Analyst Price Target


Over the past 170 days, ATRA's average price target has gone down $7.79.

Over the past 51 weeks, ATRA's average upside potential has been 121.35%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-22 11 78 10 35.29 13.77 156.28%
2021-03-20 7 78 10 35.57 15.04 136.5%
2021-02-06 11 78 9 32.89 20.32 61.86%
2021-04-25 6 78 10 35.57 14.14 151.56%
2021-07-10 11 78 10 35.29 14.15 149.4%

ATRA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 61 days, ATRA's average broker recommendation rating improved by 0.29.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Atara Biotherapeutics Inc's variance in analysts' estimates is lower than -61.45% of them.
  • ATRA has a greater number of analysts covering the stock than 461.86% of stocks in the small market cap category.
  • In the context of Pharmaceutical Products stocks, Atara Biotherapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 164.53% of them.
  • In the context of stocks in the small market cap category, Atara Biotherapeutics Inc's average analyst price target is higher than 375.73% of them.

In the Pharmaceutical Products industry, ATHA, APTO, and AMAM are the three stocks most similar to Atara Biotherapeutics Inc regarding the price target and analyst recommendation information presented here.

Is ATRA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6643 seconds.